No paralogue variants have been mapped to residue 44 for RYR1.
RYR1 | RTDDEVVLQCSATVLKEQLKLCLAAEGFGN>R<LCFLEPTSNAQNVPPDLAICCFVLEQSLSV | 74 |
RYR2 | RTDDEVVLQCTATIHKEQQKLCLAAEGFGN>R<LCFLESTSNSKNVPPDLSICTFVLEQSLSV | 75 |
RYR3 | RTEDEVVLQCIATIHKEQRKFCLAAEGLGN>R<LCFLEPTSEAKYIPPDLCVCNFVLEQSLSV | 76 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.R44C | c.130C>T | Other Myopathy | rs193922748 | SIFT: Polyphen: | |
Reports | Other Myopathy | Scanning for mutations of the ryanodine receptor (RYR1) gene by denaturing HPLC: detection of three novel malignant hyperthermia alleles. Clin Chem. 2003 49(5):761-8. 12709367 | |||
Other Myopathy | Disease mutations in the ryanodine receptor N-terminal region couple to a mobile intersubunit interface. Nat Commun. 2013 4:1506. doi: 10.1038/ncomms2501. 23422674 | ||||
Other Myopathy | Skeletal muscle ryanodine receptor mutations associated with malignant hyperthermia showed enhanced intensity and sensitivity to triggering drugs when expressed in human embryonic kidney cells. Anesthesiology. 2013 119(1):111-8. doi: 10.1097/ALN.0b013e31828cebfe. 23459219 | ||||
p.R44H | c.131G>A | Other Myopathy | rs139161723 | SIFT: Polyphen: | |
Reports | Unknown | Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res. 2015 25(3):305-15. doi: 10.1101/gr.183483.114. 25637381 |